Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

Clinical trial NCT07651878 · RECRUITING

Trial details

NCT number: NCT07651878
Sponsor: Mendus
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CML (Chronic Myelogenous Leukemia)

Start date: 2026-04-14
Primary completion: 2029-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.